MedPage Today: Encouraging data on treatment for certain stroke population
UC's Mistry comments on recent study in accompanying editorial
A recent study found that using clot-busting drugs in stroke patients who had recently ingested blood thinners did not raise the risk of bleeding complications.
The study found that patients who had taken a blood thinner (also known as a direct oral anticoagulant or DOAC) within 48 hours prior to being treated with clot-busting drugs had a lower incidence of symptomatic intracranial hemorrhage (sICH), the most-feared bleeding complication of stroke.
Eva Mistry, MBBS, wrote an accompanying editorial in JAMA following the publication of the study. MedPage Today highlighted the research and Mistry's editorial.
"Notwithstanding the small number of patients in each group, it is reassuring to see that rates of sICH were comparable among these selection strategies," said Mistry, assistant professor in the Department of Neurology and Rehabilitation medicine in UC’s College of Medicine and a UC Health physician.
"Despite the limitations of the study design and enrolled population, these data may be used by clinicians to make individualized decisions regarding thrombolysis among patients with recent DOAC use. Importantly, this study lays the foundation for prospective, well-powered studies that definitively determine the safety of thrombolysis in this population," Mistry continued.
Read the MedPage Today article.
Featured photo at top of brain courtesy of iStock.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.